Virtual opioid agonist treatment: Alberta’s virtual opioid dependency program and outcomes

BACKGROUND: Virtually delivered healthcare (telehealth, telemedicine) has the potential to reduce gaps in access to opioid agonist therapy (OAT). Barriers to accessing OAT such as lack of transportation, in-person induction requirements, employment demands and limited childcare options reduce treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Day, Nathaniel, Wass, Maureen, Smith, Kelly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330968/
https://www.ncbi.nlm.nih.gov/pubmed/35902924
http://dx.doi.org/10.1186/s13722-022-00323-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330968/
https://www.ncbi.nlm.nih.gov/pubmed/35902924
http://dx.doi.org/10.1186/s13722-022-00323-4

Ejemplares similares